State Ledger
Company profile

COGNITION THERAPEUTICS INC CIK 1455365

Ticker
CGTX (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Purchase, NY 10577
Fiscal year end
2025 (FY)
Market Data
Close
$0.88
Change
-$0.02
Change %
-2.17%
Volume
2,929

CGTX · trading date Oct 9, 2026 · previous close $0.89 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$23.49M
Total assets
$48.39M
Total liabilities
$14.12M
Stockholders' equity
$34.27M
Cash & equivalents
$36.81M
Operating income
-$47.80M
Operating cash flow
-$24.59M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-26. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
29.2%
Equity / assets
70.8%
CapEx / revenue
—
Operating cash flow / net income
1.05×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$23.49M $48.39M $14.12M $34.27M
2024 — -$33.97M $30.23M $11.48M $18.75M
2023 — -$25.79M $35.16M $10.69M $24.47M
2022 — -$21.40M $50.43M $10.18M $40.25M
2021 — -$11.72M $59.14M $7.86M $51.27M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-07
Financials filed via
Form 10-K
filed 2026-03-26

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Purchase, NY 10577
2500 WESTCHESTER AVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:43 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies